DECIBEL THERAPEUTICS

decibel-therapeutics-logo

Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery.

#SimilarOrganizations #People #Financial #Website #More

DECIBEL THERAPEUTICS

Industry:
Biotechnology Medical Device Therapeutics

Founded:
2015-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.decibeltx.com

Total Employee:
51+

Status:
Active

Contact:
(617) 370-8701

Email Addresses:
[email protected]

Total Funding:
189.2 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag


Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

goldfinch-biopharma-logo

Goldfinch Biopharma

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.


Current Advisors List

anthony-philippakis_image

Anthony Philippakis Board Of director @ Decibel Therapeutics
Board_member

jens-eckstein_image

Jens Eckstein Board Director @ Decibel Therapeutics
Board_member

matthew-foy_image

Matthew Foy Board Member @ Decibel Therapeutics
Board_member
2019-01-01

Current Employees Featured

erik-larsen_image

Erik Larsen
Erik Larsen Senior Director, Product and Market Strategy @ Decibel Therapeutics
Senior Director, Product and Market Strategy
2016-03-07

gabriel-corfas_image

Gabriel Corfas
Gabriel Corfas Founder @ Decibel Therapeutics
Founder
2015-10-01

not_available_image

M. Charles Liberman
M. Charles Liberman Founder @ Decibel Therapeutics
Founder

ronald-vigliotta_image

Ronald Vigliotta
Ronald Vigliotta VICE PRESIDENT, FINANCE @ Decibel Therapeutics
VICE PRESIDENT, FINANCE

john-j-keilty_image

John J. Keilty
John J. Keilty Chief Data Sciences Officer @ Decibel Therapeutics
Chief Data Sciences Officer
2017-01-01

anna-trask_image

Anna Trask
Anna Trask EVP and CHIEF PEOPLE, COMMUNITY and CULTURE OFFICER @ Decibel Therapeutics
EVP and CHIEF PEOPLE, COMMUNITY and CULTURE OFFICER
2018-01-01

heather-wolff_image

Heather Wolff
Heather Wolff VICE PRESIDENT, CLINICAL DEVELOPMENT OPERATIONS @ Decibel Therapeutics
VICE PRESIDENT, CLINICAL DEVELOPMENT OPERATIONS

elisabeth-leiderman_image

Elisabeth Leiderman
Elisabeth Leiderman CFO @ Decibel Therapeutics
CFO
2020-01-01

laurence-reid_image

Laurence Reid
Laurence Reid Chief Executive Officer @ Decibel Therapeutics
Chief Executive Officer
2020-11-01

john-j-lee_image

John J. Lee
John J. Lee Chief Development Officer @ Decibel Therapeutics
Chief Development Officer
2021-02-01

Founder


gabriel-corfas_image

Gabriel Corfas

not_available_image

M. Charles Liberman

Stock Details


Company's stock symbol is NASDAQ:DBTX

Investors List

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series D - Decibel Therapeutics

blackrock_image

BlackRock

BlackRock investment in Series D - Decibel Therapeutics

sr-one_image

SR One

SR One investment in Series D - Decibel Therapeutics

s-cubed-capital_image

S-Cubed Capital

S-Cubed Capital investment in Series D - Decibel Therapeutics

casdin-capital_image

Casdin Capital

Casdin Capital investment in Series D - Decibel Therapeutics

google-ventures_image

GV

GV investment in Series D - Decibel Therapeutics

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series D - Decibel Therapeutics

sobrato-capital_image

Sobrato Capital

Sobrato Capital investment in Series D - Decibel Therapeutics

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series D - Decibel Therapeutics

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series D - Decibel Therapeutics

Official Site Inspections

http://www.decibeltx.com Semrush global rank: 2.55 M Semrush visits lastest month: 6.9 K

  • Host name: ec2-54-210-177-205.compute-1.amazonaws.com
  • IP address: 54.210.177.205
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Decibel Therapeutics" on Search Engine